Wells Fargo’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Wells Fargo’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,888	Closed	-$14.7K	–	7783
2023 Q3	$14.7K	Buy	1,888 +2	+0.1%	+$22	﹤0.01%	5704
2023 Q2	$27.4K	Hold	1,886	–	–	﹤0.01%	5644
2023 Q1	$34.9K	Hold	1,886	–	–	﹤0.01%	5362
2022 Q4	$28.3K	Sell	1,886 -70	-4%	-$1.22K	﹤0.01%	5118
2022 Q3	$33K	Hold	1,956	–	–	﹤0.01%	5149
2022 Q2	$46K	Sell	1,956 -270	-12%	-$5.43K	﹤0.01%	5067
2022 Q1	$51K	Buy	2,226 +833	+60%	+$16.6K	﹤0.01%	5651
2021 Q4	$24K	Buy	1,393 +271	+24%	+$5.67K	﹤0.01%	6278
2021 Q3	$30K	Buy	1,122 +7	+0.6%	+$153	﹤0.01%	5825
2021 Q2	$32K	Buy	+1,115	New	+$30.3K	﹤0.01%	5737

Other funds holding ZIVO

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Wells Fargo's ZIVO Position: Q4 2023 in Review

Wells Fargo sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q4 2023, closing a stake of 1,888 shares — an estimated $14.7K sold.

Wells Fargo first reported a position in ZIVO in Q2 2021 and held it in 10 quarters. The position peaked at $51K in Q1 2022. 2 funds tracked by Wall St. Rank hold ZIVO as of Q4 2023.

Wells Fargo reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Wells Fargo sold 1,888 Zivo Bioscience, Inc. Common Stock shares in Q4 2023, an estimated $14.7K.
Wells Fargo first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Wells Fargo's Zivo Bioscience, Inc. Common Stock position peaked at $51K in Q1 2022.
2 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.